CAN J DIABETES 润色咨询

Canadian Journal of Diabetes

出版年份:2002 年文章数:1101 投稿命中率: 开通期刊会员,数据随心看

出版周期:Quarterly 自引率:4.4% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2094903, encodeId=7067209490339, content=审稿速度:3.0<br>经验分享:刚接收一篇,分享下投稿经历,希望对大家有帮助。5.17 submitted to journal. 5.20 under review. 8.9 major revision. 9.9 revision submitted to journal. 10.7 minor revision. 10.19 accepted., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/9087fd4e29aafedf1ee18877e473107c/12ba0027f7104b2200bd44f501456e24.jpg, createdBy=1a16105917, createdName=clickwong, createdTime=Thu Oct 20 09:54:28 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101281, encodeId=2396110128147, content=什么样的题目能让审稿人眼前一亮?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101282, encodeId=c7b011012823a, content=审稿人一般更青睐于什么样的题目?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540579, encodeId=8f9b5405e9cc, content=可恨,去年我发表了一篇,还有2分多,今年就1分多了,明年难道还要降?谁愿意投它呢!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=371, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13717005588, createdTime=Tue Jul 18 18:43:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540303, encodeId=2313540303a1, content=太狠了!跌了这么多,以后谁还敢投??, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ding_ying, createdTime=Tue Jul 18 18:39:00 CST 2017, time=2017-07-18, status=1, ipAttribution=)]
    2022-10-20 clickwong

    审稿速度:3.0
    经验分享:刚接收一篇,分享下投稿经历,希望对大家有帮助。5.17 submitted to journal. 5.20 under review. 8.9 major revision. 9.9 revision submitted to journal. 10.7 minor revision. 10.19 accepted.

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2094903, encodeId=7067209490339, content=审稿速度:3.0<br>经验分享:刚接收一篇,分享下投稿经历,希望对大家有帮助。5.17 submitted to journal. 5.20 under review. 8.9 major revision. 9.9 revision submitted to journal. 10.7 minor revision. 10.19 accepted., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/9087fd4e29aafedf1ee18877e473107c/12ba0027f7104b2200bd44f501456e24.jpg, createdBy=1a16105917, createdName=clickwong, createdTime=Thu Oct 20 09:54:28 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101281, encodeId=2396110128147, content=什么样的题目能让审稿人眼前一亮?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101282, encodeId=c7b011012823a, content=审稿人一般更青睐于什么样的题目?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540579, encodeId=8f9b5405e9cc, content=可恨,去年我发表了一篇,还有2分多,今年就1分多了,明年难道还要降?谁愿意投它呢!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=371, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13717005588, createdTime=Tue Jul 18 18:43:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540303, encodeId=2313540303a1, content=太狠了!跌了这么多,以后谁还敢投??, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ding_ying, createdTime=Tue Jul 18 18:39:00 CST 2017, time=2017-07-18, status=1, ipAttribution=)]
    2021-12-28 桑晒麦拉

    什么样的题目能让审稿人眼前一亮?

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2094903, encodeId=7067209490339, content=审稿速度:3.0<br>经验分享:刚接收一篇,分享下投稿经历,希望对大家有帮助。5.17 submitted to journal. 5.20 under review. 8.9 major revision. 9.9 revision submitted to journal. 10.7 minor revision. 10.19 accepted., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/9087fd4e29aafedf1ee18877e473107c/12ba0027f7104b2200bd44f501456e24.jpg, createdBy=1a16105917, createdName=clickwong, createdTime=Thu Oct 20 09:54:28 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101281, encodeId=2396110128147, content=什么样的题目能让审稿人眼前一亮?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101282, encodeId=c7b011012823a, content=审稿人一般更青睐于什么样的题目?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540579, encodeId=8f9b5405e9cc, content=可恨,去年我发表了一篇,还有2分多,今年就1分多了,明年难道还要降?谁愿意投它呢!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=371, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13717005588, createdTime=Tue Jul 18 18:43:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540303, encodeId=2313540303a1, content=太狠了!跌了这么多,以后谁还敢投??, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ding_ying, createdTime=Tue Jul 18 18:39:00 CST 2017, time=2017-07-18, status=1, ipAttribution=)]
    2021-12-27 桑晒麦拉

    审稿人一般更青睐于什么样的题目?

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2094903, encodeId=7067209490339, content=审稿速度:3.0<br>经验分享:刚接收一篇,分享下投稿经历,希望对大家有帮助。5.17 submitted to journal. 5.20 under review. 8.9 major revision. 9.9 revision submitted to journal. 10.7 minor revision. 10.19 accepted., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/9087fd4e29aafedf1ee18877e473107c/12ba0027f7104b2200bd44f501456e24.jpg, createdBy=1a16105917, createdName=clickwong, createdTime=Thu Oct 20 09:54:28 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101281, encodeId=2396110128147, content=什么样的题目能让审稿人眼前一亮?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101282, encodeId=c7b011012823a, content=审稿人一般更青睐于什么样的题目?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540579, encodeId=8f9b5405e9cc, content=可恨,去年我发表了一篇,还有2分多,今年就1分多了,明年难道还要降?谁愿意投它呢!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=371, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13717005588, createdTime=Tue Jul 18 18:43:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540303, encodeId=2313540303a1, content=太狠了!跌了这么多,以后谁还敢投??, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ding_ying, createdTime=Tue Jul 18 18:39:00 CST 2017, time=2017-07-18, status=1, ipAttribution=)]
    2017-07-18 13717005588

    可恨,去年我发表了一篇,还有2分多,今年就1分多了,明年难道还要降?谁愿意投它呢!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2094903, encodeId=7067209490339, content=审稿速度:3.0<br>经验分享:刚接收一篇,分享下投稿经历,希望对大家有帮助。5.17 submitted to journal. 5.20 under review. 8.9 major revision. 9.9 revision submitted to journal. 10.7 minor revision. 10.19 accepted., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/9087fd4e29aafedf1ee18877e473107c/12ba0027f7104b2200bd44f501456e24.jpg, createdBy=1a16105917, createdName=clickwong, createdTime=Thu Oct 20 09:54:28 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101281, encodeId=2396110128147, content=什么样的题目能让审稿人眼前一亮?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101282, encodeId=c7b011012823a, content=审稿人一般更青睐于什么样的题目?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540579, encodeId=8f9b5405e9cc, content=可恨,去年我发表了一篇,还有2分多,今年就1分多了,明年难道还要降?谁愿意投它呢!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=371, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13717005588, createdTime=Tue Jul 18 18:43:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540303, encodeId=2313540303a1, content=太狠了!跌了这么多,以后谁还敢投??, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ding_ying, createdTime=Tue Jul 18 18:39:00 CST 2017, time=2017-07-18, status=1, ipAttribution=)]
    2017-07-18 ding_ying

    太狠了!跌了这么多,以后谁还敢投??

    0

共8条页码: 1/1页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分